Xlt Biopharmaceuticals - Cambridge, Massachusetts 02142

Xlt Biopharmaceuticals is categorized under Nonclassified Establishments in Cambridge, MA .

Business Name: Xlt Biopharmaceuticals
Address: 1 Broadway, Cambridge, Massachusetts 02142
Phone Number: (617) 621-1570
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Nonclassified Establishments
SIC Code: 9999
NAICS Code: 9999900
Share This Business:
Related Businesses: Bio Dynamics - Cambridge, MA 02142
Kvl Sonesta Boston - Cambridge, MA 02142
Jeffrey Berman Foundation - Cambridge, MA 02142
Place Switch - Cambridge, MA 02142
Indigobay Ventures - Cambridge, MA 02142
S Q R R L Data Inc - Cambridge, MA 02142
Spot on Networks LLC - Cambridge, MA 02142
Virtual Knowledge Workers Inc - Cambridge, MA 02142
Housing Corp-Oakwood - Cambridge, MA 02142
Venture Start Com Inc - Cambridge, MA 02142
Symbolics Inc - Cambridge, MA 02142
Neuron Systems - Cambridge, MA 02142
Nech Cooperate - Cambridge, MA 02142
Housing National Corp - Cambridge, MA 02142
Patni - Cambridge, MA 02142
Job Site Berry & Son - Cambridge, MA 02142
Flagship Centures Inc - Cambridge, MA 02142
I-Phrase - Cambridge, MA 02142
Cypress Communiations - Cambridge, MA 02142
Saab Technology Group - Cambridge, MA 02142

The company Xlt Biopharmaceuticals provides BOTH services in the form of Nonclassified Establishments from its single location in Massachusetts. 1 to 4 employees work for Xlt Biopharmaceuticals, and the business now earns Unknown per annum.

Xlt Biopharmaceuticals was launched in 0 and is classified under SIC code and category 9999 , and NAICS number and grouping 9999900 . To contact Xlt Biopharmaceuticals, please call with the phone number (617) 621-1570 or visit its single location at 1 Broadway in Cambridge, Massachusetts 02142.

The location of the single location can also be found using the coordinates 42.362035,-71.082517. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.